Literature DB >> 25773519

Molecular mechanisms of MLL-associated leukemia.

Akihiko Yokoyama1.   

Abstract

Gene rearrangements of the mixed lineage leukemia (MLL) gene cause aggressive leukemia. The fusion of MLL and its partner genes generates various MLL fusion genes, and their gene products trigger aberrant self-renewal of hematopoietic progenitors leading to leukemia. Since the identification of the MLL gene two decades ago, a substantial amount of information has been obtained regarding the mechanisms by which MLL mutations cause leukemia. Wild-type MLL maintains the expression of Homeobox (HOX) genes during development. MLL activates the expression of posterior HOX-A genes in the hematopoietic lineage to stimulate the expansion of immature progenitors. MLL fusion proteins constitutively activate the HOX genes, causing aberrant self-renewal. The modes of transcriptional activation vary depending on the fusion partners and can be categorized into at least four groups. Here I review the recent progress in research related to the molecular mechanisms of MLL fusion-dependent leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25773519     DOI: 10.1007/s12185-015-1774-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  95 in total

1.  Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6.

Authors:  Michaela Liedtke; Paul M Ayton; Tim C P Somervaille; Kevin S Smith; Michael L Cleary
Journal:  Blood       Date:  2010-04-15       Impact factor: 22.113

2.  HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription.

Authors:  Nanhai He; Min Liu; Joanne Hsu; Yuhua Xue; Seemay Chou; Alma Burlingame; Nevan J Krogan; Tom Alber; Qiang Zhou
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

3.  Menin critically links MLL proteins with LEDGF on cancer-associated target genes.

Authors:  Akihiko Yokoyama; Michael L Cleary
Journal:  Cancer Cell       Date:  2008-07-08       Impact factor: 31.743

4.  MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice.

Authors:  Chi Wai So; Holger Karsunky; Emmanuelle Passegué; Antonio Cozzio; Irving L Weissman; Michael L Cleary
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

5.  Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis.

Authors:  Lesley F Drynan; Richard Pannell; Alan Forster; Nicole M M Chan; Florencia Cano; Angelika Daser; Terence H Rabbitts
Journal:  EMBO J       Date:  2005-08-11       Impact factor: 11.598

6.  Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia.

Authors:  C Lavau; C Du; M Thirman; N Zeleznik-Le
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

7.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

8.  Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias.

Authors:  D C Tkachuk; S Kohler; M L Cleary
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

9.  Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties.

Authors:  Akihiko Yokoyama; Issay Kitabayashi; Paul M Ayton; Michael L Cleary; Misao Ohki
Journal:  Blood       Date:  2002-06-28       Impact factor: 22.113

10.  Trithorax regulates multiple homeotic genes in the bithorax and Antennapedia complexes and exerts different tissue-specific, parasegment-specific and promoter-specific effects on each.

Authors:  T R Breen; P J Harte
Journal:  Development       Date:  1993-01       Impact factor: 6.868

View more
  13 in total

1.  miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.

Authors:  Laurent Ehrlich; Chad Hall; Julie Venter; David Dostal; Francesca Bernuzzi; Pietro Invernizzi; Fanyin Meng; Jerome P Trzeciakowski; Tianhao Zhou; Holly Standeford; Gianfranco Alpini; Terry C Lairmore; Shannon Glaser
Journal:  Am J Pathol       Date:  2017-01-11       Impact factor: 4.307

2.  Reemergence of translocation t(11;19)(q23;p13.1) in the absence of clinically overt leukemia.

Authors:  Suguru Uemura; Akihiro Tamura; Atsuro Saito; Daiichiro Hasegawa; Nanako Nino; Takehito Yokoi; Teppei Tahara; Aiko Kozaki; Kenji Kishimoto; Toshiaki Ishida; Keiichiro Kawasaki; Takeshi Mori; Noriyuki Nishimura; Minenori Ishimae; Mariko Eguchi; Yoshiyuki Kosaka
Journal:  Int J Hematol       Date:  2017-07-01       Impact factor: 2.490

3.  Hematopoietic stem cell transplantation for pediatric mature B-cell acute lymphoblastic leukemia with non-L3 morphology and MLL-AF9 gene fusion: three case reports and review of the literature.

Authors:  Takeo Sarashina; Haruko Iwabuchi; Naoyuki Miyagawa; Masahiro Sekimizu; Tomoko Yokosuka; Kunio Fukuda; Satoshi Hamanoue; Fuminori Iwasaki; Shoko Goto; Masae Shiomi; Chihaya Imai; Hiroaki Goto
Journal:  Int J Hematol       Date:  2016-03-18       Impact factor: 2.490

4.  Krüppel-like Factor 4 Supports the Expansion of Leukemia Stem Cells in MLL-AF9-driven Acute Myeloid Leukemia.

Authors:  Andrew Henry Lewis; Cory Seth Bridges; David Neal Moorshead; Taylor J Chen; Wa Du; Barry Zorman; Pavel Sumazin; Monica Puppi; H Daniel Lacorazza
Journal:  Stem Cells       Date:  2022-08-25       Impact factor: 5.845

5.  High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

Authors:  George S Laszlo; Todd A Alonzo; Chelsea J Gudgeon; Kimberly H Harrington; Alex Kentsis; Robert B Gerbing; Yi-Cheng Wang; Rhonda E Ries; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Soheil Meshinchi; Roland B Walter
Journal:  J Hematol Oncol       Date:  2015-10-20       Impact factor: 17.388

6.  The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viability.

Authors:  William Grey; Adam Ivey; Thomas A Milne; Torsten Haferlach; David Grimwade; Frank Uhlmann; Edwige Voisset; Veronica Yu
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-09-20       Impact factor: 4.739

7.  First case of B ALL with KMT2A-MAML2 rearrangement: a case report.

Authors:  Estelle Menu; Nathalie Beaufils; Fabrice Usseglio; Estelle Balducci; Marina Lafage Pochitaloff; Regis Costello; Jean Gabert
Journal:  BMC Cancer       Date:  2017-05-23       Impact factor: 4.430

Review 8.  Epigenetics in normal and malignant hematopoiesis: An overview and update 2017.

Authors:  Susumu Goyama; Toshio Kitamura
Journal:  Cancer Sci       Date:  2017-04-20       Impact factor: 6.716

9.  Opposing effects of acute versus chronic inhibition of p53 on decitabine's efficacy in myeloid neoplasms.

Authors:  Moe Tamura; Taishi Yonezawa; Xiaoxiao Liu; Shuhei Asada; Yasutaka Hayashi; Tomofusa Fukuyama; Yosuke Tanaka; Toshio Kitamura; Susumu Goyama
Journal:  Sci Rep       Date:  2019-06-03       Impact factor: 4.379

10.  Trithorax group genes in hematopoiesis.

Authors:  Jennifer Chase; Jolanta Grembecka; Ivan Maillard
Journal:  Oncotarget       Date:  2015-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.